These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1725027)

  • 1. Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study.
    Vasmant D; Lendresse P; Lemarie JC; Gallet M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S144-6. PubMed ID: 1725027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
    Schnaper HW
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S128-30. PubMed ID: 1725021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ramipril on ambulatory blood pressure: a multicenter trial.
    Burris JF
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S131-3. PubMed ID: 1725022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ramipril against atenolol in controlling mild-to-moderate hypertension.
    Lenox-Smith AJ; Street RB; Kendall FD
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S150-2. PubMed ID: 1725029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis.
    Erhard W; Lindner U; Krall H; Breitstadt A; Pfeiffer C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S160-4. PubMed ID: 1725032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of ramipril in a multicenter study of mild-to-moderate hypertension in general practice.
    Carré A; Vasmant D; Elmalem J; Thiéry P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S141-3. PubMed ID: 1725026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive efficacy, tolerance, and safety of ramipril in young vs. old patients: a retrospective study.
    Saalbach R; Wochnik G; Mauersberger H; Cairns V; Breitstadt A; Rangoonwala B
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S134-6. PubMed ID: 1725023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ramipril in combination with hydrochlorothiazide: results of a long-term study.
    Heidbreder D; Froer KL; Bauer B; Cairns V; Breitstadt A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S169-73. PubMed ID: 1725034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive efficacy, tolerance, and safety of long-term treatment with ramipril in patients with mild-to-moderate essential hypertension.
    Schreiner M; Berendes B; Verho M; Langley A; Cairns V
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S137-40. PubMed ID: 1725024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
    Bauer B; Lorenz H; Zahlten R
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
    Witte PU; Walter U
    Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo.
    Villamil AS; Cairns V; Witte PU; Bertolasi CA
    Am J Cardiol; 1987 Apr; 59(10):110D-114D. PubMed ID: 3034017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [French multicenter study of Triatec (ramipril) in ambulatory patients: methodology and trial structure].
    Vasmant D; Thiéry P
    Rev Prat; 1990 Jun; 40(18 Suppl):21-6. PubMed ID: 2143595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D; Bender N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relation of the angiotensin converting enzyme inhibitor ramipril in mild to moderate essential hypertension.
    Walter U; Forthofer R; Witte PU
    Am J Cardiol; 1987 Apr; 59(10):125D-132D. PubMed ID: 3034021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramipril: a review of the new ACE inhibitor.
    Mills TP
    J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension.
    Ludvik B; Kueenburg E; Brunnbauer M; Schernthaner G; Prager R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S157-9. PubMed ID: 1725031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.